Filing Details

Accession Number:
0001237899-12-000093
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-04 16:09:27
Reporting Period:
2012-11-30
Filing Date:
2012-12-04
Accepted Time:
2012-12-04 16:09:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226687 William Roberts 777 Old Saw Mill River Road
Tarrytown NY 10591
Vp Regulat Dev & Med Safety No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-11-05 26,000 $0.00 16,644 No 5 G Direct
Common Stock Acquisiton 2012-11-27 11,500 $0.00 11,500 No 5 G Indirect by CRUT
Common Stock Disposition 2012-11-30 224 $177.43 11,276 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 430 $178.27 10,846 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 2,600 $179.43 8,246 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 5,010 $180.67 3,236 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 1,515 $181.47 1,721 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 521 $182.44 1,200 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 800 $183.58 400 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 200 $184.29 200 No 4 S Indirect by CRUT
Common Stock Disposition 2012-11-30 200 $186.00 0 No 4 S Indirect by CRUT
Common Stock Acquisiton 2012-09-04 19,947 $0.00 19,947 No 5 G Indirect by Spouse
Common Stock Acquisiton 2012-11-05 26,000 $0.00 45,947 No 5 G Indirect by Spouse
Common Stock Disposition 2012-11-27 11,500 $0.00 17,447 No 5 G Indirect by Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 4 S Indirect by CRUT
No 5 G Indirect by Spouse
No 5 G Indirect by Spouse
No 5 G Indirect by Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 17,000 Indirect by GRAT
Common Stock 1,200 Indirect by trust for daught
Common Stock 4,331 Indirect By 401(k) Plan
Common Stock 1,200 Indirect by trust for daught
Footnotes
  1. Gift of Common Stock by reporting person to spouse.
  2. Transfer of Common Stock by spouse to Charitable Remainder Unitrust (CRUT).
  3. Represents volume-weighted average price of sales of 224 shares of Company stock on November 30, 2012 at prices ranging from $177.42 to $177.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
  4. Represents volume-weighted average price of sales of 430 shares of Company stock on November 30, 2012 at prices ranging from $178.03 to $178.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
  5. Represents volume-weighted average price of sales of 2,600 shares of Company stock on November 30, 2012 at prices ranging from $179.05 to $179.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
  6. Represents volume-weighted average price of sales of 5,010 shares of Company stock on November 30, 2012 at prices ranging from $180.02 to $180.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
  7. Represents volume-weighted average price of sales of 1,515 shares of Company stock on November 30, 2012 at prices ranging from $181.00 to $181.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
  8. Represents volume-weighted average price of sales of 521 shares of Company stock on November 30, 2012 at prices ranging from $182.14 to $182.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
  9. Represents volume-weighted average price of sales of 800 shares of Company stock on November 30, 2012 at prices ranging from $183.21 to $183.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
  10. Represents volume-weighted average price of sales of 200 shares of Company stock on November 30, 2012 at prices ranging from $184.16 to $184.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.